[
  {
    "ts": "2026-01-05T13:00:00+00:00",
    "headline": "Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America",
    "summary": "Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time. This advancement opens new possibilities for the more than 100 million Americans living with obesity.2 Wegovy® pill was approved on December 22, 2025 and is used with a reduced calorie diet and increased physical activity for adults with obesity, or with overweight who also have weight-related medical problems, to help them lose weight and keep i",
    "url": "https://finance.yahoo.com/news/novo-nordisks-wegovy-pill-first-130000047.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "38e27820-b910-3f1b-b5cf-88a2691e2147",
      "content": {
        "id": "38e27820-b910-3f1b-b5cf-88a2691e2147",
        "contentType": "STORY",
        "title": "Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America",
        "description": "",
        "summary": "Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time. This advancement opens new possibilities for the more than 100 million Americans living with obesity.2 Wegovy® pill was approved on December 22, 2025 and is used with a reduced calorie diet and increased physical activity for adults with obesity, or with overweight who also have weight-related medical problems, to help them lose weight and keep i",
        "pubDate": "2026-01-05T13:00:00Z",
        "displayTime": "2026-01-05T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/b33acdc147ba24e772b0088bfe8f2846",
          "originalWidth": 400,
          "originalHeight": 290,
          "caption": "Image of 1.5mg starter dose of Wegovy® pill",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IzCMTp8XPN_b.l66dYe66A--~B/aD0yOTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b33acdc147ba24e772b0088bfe8f2846.cf.webp",
              "width": 400,
              "height": 290,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oZ1HX6ENL.39DAnhWQuRkg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b33acdc147ba24e772b0088bfe8f2846.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisks-wegovy-pill-first-130000047.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisks-wegovy-pill-first-130000047.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "COST"
            },
            {
              "symbol": "LFMD"
            },
            {
              "symbol": "WW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T14:57:25+00:00",
    "headline": "Novo Nordisk Stock Rises on Launch of Weight-Loss Pills",
    "summary": "Novo Nordisk’s shares rallied after the drugmaker said its new Wegovy weight-loss pill is now broadly available in the U.S., following regulatory approval last month.  The Wegovy product is the first GLP-1 pill approved specifically for weight loss.  It will tap into what analysts expect will be substantial demand from consumers seeking an alternative to the injections that have dominated the anti-obesity market to date.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-05-2026/card/novo-nordisk-stock-rises-on-launch-of-weight-loss-pills-d7qEImU2xtm9BLVcdKhI?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "bfd61aed-0231-3a5c-ba68-1e425e1ccdb8",
      "content": {
        "id": "bfd61aed-0231-3a5c-ba68-1e425e1ccdb8",
        "contentType": "STORY",
        "title": "Novo Nordisk Stock Rises on Launch of Weight-Loss Pills",
        "description": "",
        "summary": "Novo Nordisk’s shares rallied after the drugmaker said its new Wegovy weight-loss pill is now broadly available in the U.S., following regulatory approval last month.  The Wegovy product is the first GLP-1 pill approved specifically for weight loss.  It will tap into what analysts expect will be substantial demand from consumers seeking an alternative to the injections that have dominated the anti-obesity market to date.",
        "pubDate": "2026-01-05T14:57:25Z",
        "displayTime": "2026-01-05T14:57:25Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/bfd61aed-0231-3a5c-ba68-1e425e1ccdb8/novo-nordisk-stock-rises-on.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-05-2026/card/novo-nordisk-stock-rises-on-launch-of-weight-loss-pills-d7qEImU2xtm9BLVcdKhI?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "COST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T13:42:00+00:00",
    "headline": "Novo Nordisk’s Wegovy Pill Now Broadly Available Across U.S.",
    "summary": "Novo Nordisk’s Wegovy weight-loss pill is now broadly available across the U.S., two weeks after it received U.S. regulatory approval, the Danish drugmaker said.",
    "url": "https://www.wsj.com/health/pharma/novo-nordisks-wegovy-pill-now-broadly-available-across-u-s-a0db33d7?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "af1d95a7-49b6-30fa-8e5e-540698320824",
      "content": {
        "id": "af1d95a7-49b6-30fa-8e5e-540698320824",
        "contentType": "STORY",
        "title": "Novo Nordisk’s Wegovy Pill Now Broadly Available Across U.S.",
        "description": "",
        "summary": "Novo Nordisk’s Wegovy weight-loss pill is now broadly available across the U.S., two weeks after it received U.S. regulatory approval, the Danish drugmaker said.",
        "pubDate": "2026-01-05T13:42:00Z",
        "displayTime": "2026-01-05T13:42:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/af1d95a7-49b6-30fa-8e5e-540698320824/novo-nordisk%E2%80%99s-wegovy-pill.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/e83d2d773541faef04f98d3a409db389",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/e0BgLnvPpwyh7Pjsw4EP6Q--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/e83d2d773541faef04f98d3a409db389.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jTiPV.FuS9unTJ78fAHifQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/e83d2d773541faef04f98d3a409db389.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/novo-nordisks-wegovy-pill-now-broadly-available-across-u-s-a0db33d7?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "COST"
            },
            {
              "symbol": "LFMD"
            },
            {
              "symbol": "WW"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T17:09:19+00:00",
    "headline": "European Equities Mostly Higher in Monday Trading; Novo Nordisk Rolls Out Wegovy Pill in US",
    "summary": "European stock markets closed mostly higher in Monday trading with the Stoxx Europe adding 0.9%, Ger",
    "url": "https://finance.yahoo.com/news/european-equities-mostly-higher-monday-170919643.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "e477fe52-72e4-3664-99bc-77b92b4c7179",
      "content": {
        "id": "e477fe52-72e4-3664-99bc-77b92b4c7179",
        "contentType": "STORY",
        "title": "European Equities Mostly Higher in Monday Trading; Novo Nordisk Rolls Out Wegovy Pill in US",
        "description": "",
        "summary": "European stock markets closed mostly higher in Monday trading with the Stoxx Europe adding 0.9%, Ger",
        "pubDate": "2026-01-05T17:09:19Z",
        "displayTime": "2026-01-05T17:09:19Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/european-equities-mostly-higher-monday-170919643.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/european-equities-mostly-higher-monday-170919643.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "^GDAXI"
            },
            {
              "symbol": "^FTSE"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "COST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T18:07:21+00:00",
    "headline": "Eli Lilly Lags In The Weight Loss Pill War. But It Has A Plan.",
    "summary": "Eli Lilly stock is falling as rival Novo Nordisk hit a milestone in the area of weight loss drugs. But Lilly has a rival drug in the pipeline.",
    "url": "https://www.investors.com/research/eli-lilly-stock-lly-weight-loss-drugs-novo-nordisk/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "e42b1d11-89cd-34e9-a4df-47c3410b4bd4",
      "content": {
        "id": "e42b1d11-89cd-34e9-a4df-47c3410b4bd4",
        "contentType": "STORY",
        "title": "Eli Lilly Lags In The Weight Loss Pill War. But It Has A Plan.",
        "description": "",
        "summary": "Eli Lilly stock is falling as rival Novo Nordisk hit a milestone in the area of weight loss drugs. But Lilly has a rival drug in the pipeline.",
        "pubDate": "2026-01-05T18:07:21Z",
        "displayTime": "2026-01-05T18:07:21Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e42b1d11-89cd-34e9-a4df-47c3410b4bd4/eli-lilly-lags-in-the-weight.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/75c01687f70f63c85d8c90296f5e1bd1",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KV5OQORJgjoFh52wtKRJaw--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/75c01687f70f63c85d8c90296f5e1bd1.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zYKDn_6gIbTTyzu33zLTjA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/75c01687f70f63c85d8c90296f5e1bd1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/research/eli-lilly-stock-lly-weight-loss-drugs-novo-nordisk/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "COST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T19:09:12+00:00",
    "headline": "Novo Nordisk Rolls Out Wegovy's Weight Loss Pill in US",
    "summary": "Novo Nordisk (NVO) said Monday that its Wegovy pill, the first oral medicine for obesity in the US,",
    "url": "https://finance.yahoo.com/news/novo-nordisk-rolls-wegovy-apos-190912348.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "995ce90a-d380-3b1c-beb6-d05ccb4e8dc7",
      "content": {
        "id": "995ce90a-d380-3b1c-beb6-d05ccb4e8dc7",
        "contentType": "STORY",
        "title": "Novo Nordisk Rolls Out Wegovy's Weight Loss Pill in US",
        "description": "",
        "summary": "Novo Nordisk (NVO) said Monday that its Wegovy pill, the first oral medicine for obesity in the US,",
        "pubDate": "2026-01-05T19:09:12Z",
        "displayTime": "2026-01-05T19:09:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/f360f3dd1acd0991db5012422fc00211",
          "originalWidth": 1000,
          "originalHeight": 666,
          "caption": "novonordisk - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eliLOTQZlBN.EI2msY8t5Q--~B/aD02NjY7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/f360f3dd1acd0991db5012422fc00211.cf.webp",
              "width": 1000,
              "height": 666,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Wm42B1.q1CBU9m2gxaHtkw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/f360f3dd1acd0991db5012422fc00211.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-rolls-wegovy-apos-190912348.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-rolls-wegovy-apos-190912348.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "WW"
            },
            {
              "symbol": "GDRX"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "LFMD"
            },
            {
              "symbol": "COST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T18:07:21+00:00",
    "headline": "Eli Lilly Lags In The Weight-Loss Pill War. But It Has A Plan.",
    "summary": "Eli Lilly stock is falling as rival Novo Nordisk hit a milestone in the area of weight-loss drugs. But Lilly has a rival drug in the pipeline.",
    "url": "https://www.investors.com/research/eli-lilly-stock-lly-weight-loss-drugs-novo-nordisk/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "e42b1d11-89cd-34e9-a4df-47c3410b4bd4",
      "content": {
        "id": "e42b1d11-89cd-34e9-a4df-47c3410b4bd4",
        "contentType": "STORY",
        "title": "Eli Lilly Lags In The Weight-Loss Pill War. But It Has A Plan.",
        "description": "",
        "summary": "Eli Lilly stock is falling as rival Novo Nordisk hit a milestone in the area of weight-loss drugs. But Lilly has a rival drug in the pipeline.",
        "pubDate": "2026-01-05T18:07:21Z",
        "displayTime": "2026-01-05T18:07:21Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e42b1d11-89cd-34e9-a4df-47c3410b4bd4/eli-lilly-lags-in-the.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/75c01687f70f63c85d8c90296f5e1bd1",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KV5OQORJgjoFh52wtKRJaw--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/75c01687f70f63c85d8c90296f5e1bd1.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zYKDn_6gIbTTyzu33zLTjA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/75c01687f70f63c85d8c90296f5e1bd1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/research/eli-lilly-stock-lly-weight-loss-drugs-novo-nordisk/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "COST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T18:52:00+00:00",
    "headline": "Biotech and Pharma Stocks Tumble as Investors Race into Energy",
    "summary": "Cash has flowed into oil stocks following the U.S.’s seizing of Venezuelan President Nicolás Maduro.",
    "url": "https://www.barrons.com/articles/biotech-stocks-fall-energy-rises-75c35259?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "c22647e0-1bce-3ead-a8dc-4936b627c5f3",
      "content": {
        "id": "c22647e0-1bce-3ead-a8dc-4936b627c5f3",
        "contentType": "STORY",
        "title": "Biotech and Pharma Stocks Tumble as Investors Race into Energy",
        "description": "",
        "summary": "Cash has flowed into oil stocks following the U.S.’s seizing of Venezuelan President Nicolás Maduro.",
        "pubDate": "2026-01-05T18:52:00Z",
        "displayTime": "2026-01-05T18:52:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/c22647e0-1bce-3ead-a8dc-4936b627c5f3/biotech-and-pharma-stocks.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/cb4f894dd9656f61d2fc81ea3041fd8c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IqNsZdgeG.WkTwyKVzIM5Q--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/cb4f894dd9656f61d2fc81ea3041fd8c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/peRwRCHKt5q9P30nb9_1Jg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/cb4f894dd9656f61d2fc81ea3041fd8c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/biotech-stocks-fall-energy-rises-75c35259?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "UNH"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "XBI"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T18:44:00+00:00",
    "headline": "McKesson Builds Earnings Momentum on Specialty and Automation",
    "summary": "McKesson posts a strong fiscal second quarter, lifts full-year EPS outlook, and shows how specialty growth and automation are reshaping its earnings power.",
    "url": "https://finance.yahoo.com/news/mckesson-builds-earnings-momentum-specialty-184400376.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a55aff09-375e-3053-8eac-655457e76df6",
      "content": {
        "id": "a55aff09-375e-3053-8eac-655457e76df6",
        "contentType": "STORY",
        "title": "McKesson Builds Earnings Momentum on Specialty and Automation",
        "description": "",
        "summary": "McKesson posts a strong fiscal second quarter, lifts full-year EPS outlook, and shows how specialty growth and automation are reshaping its earnings power.",
        "pubDate": "2026-01-05T18:44:00Z",
        "displayTime": "2026-01-05T18:44:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/62b53c8baa0ab2c805e2a16ae76ef3b8",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tj8ZNhTW.EaFq0gf4epBdA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/62b53c8baa0ab2c805e2a16ae76ef3b8.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/m7FUnW0Rc7kH4rOUyfanWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/62b53c8baa0ab2c805e2a16ae76ef3b8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mckesson-builds-earnings-momentum-specialty-184400376.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mckesson-builds-earnings-momentum-specialty-184400376.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MCK"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "CAH"
            },
            {
              "symbol": "COR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T20:43:30+00:00",
    "headline": "Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs",
    "summary": "The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to injectable treatments that have driven soaring demand.",
    "url": "https://decrypt.co/353632/novo-nordisk-wegovy-pill-expanding-access-glp-1-weight-loss-drugs",
    "source": "decrypt",
    "provider": "yfinance",
    "raw": {
      "id": "6dc1c709-5c80-300e-930a-499d3c77a72d",
      "content": {
        "id": "6dc1c709-5c80-300e-930a-499d3c77a72d",
        "contentType": "STORY",
        "title": "Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs",
        "description": "",
        "summary": "The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to injectable treatments that have driven soaring demand.",
        "pubDate": "2026-01-05T20:43:30Z",
        "displayTime": "2026-01-05T20:43:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/decrypt_157/2d2e9e12cfd0c85c801bd9d38e34e850",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.zPt.0uavmUFQwRkYNqFWA--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/decrypt_157/2d2e9e12cfd0c85c801bd9d38e34e850.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cqHCKc7D5R.LsT18t_XMrw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/decrypt_157/2d2e9e12cfd0c85c801bd9d38e34e850.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "decrypt",
          "url": "https://decrypt.co/"
        },
        "canonicalUrl": {
          "url": "https://decrypt.co/353632/novo-nordisk-wegovy-pill-expanding-access-glp-1-weight-loss-drugs",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-launches-149-wegovy-204330290.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "COST"
            },
            {
              "symbol": "LFMD"
            },
            {
              "symbol": "WW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]